Melikyan Gregory B, Platt Emily J, Kabat David
Institute of Human Virology, University of Maryland School of Medicine,725 W, Lombard St,, Baltimore, MD 21201, USA.
Retrovirology. 2007 Aug 8;4:55. doi: 10.1186/1742-4690-4-55.
HIV-1 envelope glycoprotein (Env) induces membrane fusion as a result of sequential binding to CD4 and chemokine receptors (CCR5 or CXCR4). The critical determinants of CCR5 coreceptor function are the N-terminal domain (Nt) and the second extracellular loop. However, mutations in gp120 adapt HIV-1 to grow on cells expressing the N-terminally truncated CCR5(Delta 18) (Platt et al., J. Virol. 2005, 79: 4357-68).
We have functionally characterized the adapted Env (designated Env(NYP)) using a quantitative cell-cell fusion assay. The rate of fusion with target cells expressing wild-type CCR5 and the resistance to fusion inhibitors was virtually identical for wild-type Env and Env(NYP), implying that the coreceptor affinity had not increased as a result of adaptation. In contrast, Env(NYP)-induced fusion with cells expressing CCR5(Delta 18) occurred at a slower rate and was extremely sensitive to the CCR5 binding inhibitor, Sch-C. Resistance to Sch-C drastically increased after pre-incubation of Env(NYP)- and CCR5(Delta 18)-expressing cells at a temperature that was not permissive to fusion. This indicates that ternary Env(NYP)-CD4-CCR5(Delta 18) complexes accumulate at sub-threshold temperature and that low-affinity interactions with the truncated coreceptor are sufficient for triggering conformational changes in the gp41 of Env(NYP) but not in wild-type Env. We also demonstrated that the ability of CCR5(Delta 18) to support fusion and infection mediated by wild-type Env can be partially reconstituted in the presence of a synthetic sulfated peptide corresponding to the CCR5 Nt. Pre-incubation of wild-type Env- and CCR5(Delta 18)-expressing cells with the sulfated peptide at sub-threshold temperature markedly increased the efficiency of fusion.
We propose that, upon binding the Nt region of CCR5, wild-type Env acquires the ability to productively engage the extracellular loop(s) of CCR5 - an event that triggers gp41 refolding and membrane merger. The adaptive mutations in Env(NYP) enable it to more readily release its hold on gp41, even when it interacts weakly with a severely damaged coreceptor in the absence of the sulfopeptide.
HIV-1包膜糖蛋白(Env)通过依次与CD4和趋化因子受体(CCR5或CXCR4)结合诱导膜融合。CCR5共受体功能的关键决定因素是N端结构域(Nt)和第二个细胞外环。然而,gp120中的突变使HIV-1能够在表达N端截短的CCR5(Δ18)的细胞上生长(普拉特等人,《病毒学杂志》,2005年,79:4357 - 68)。
我们使用定量细胞-细胞融合试验对适应性Env(命名为Env(NYP))进行了功能表征。野生型Env和Env(NYP)与表达野生型CCR5的靶细胞的融合速率以及对融合抑制剂的抗性几乎相同,这意味着共受体亲和力并未因适应性而增加。相比之下,Env(NYP)诱导的与表达CCR5(Δ18)的细胞的融合速率较慢,并且对CCR5结合抑制剂Sch-C极为敏感。在不允许融合的温度下对表达Env(NYP)和CCR5(Δ18)的细胞进行预孵育后,对Sch-C的抗性大幅增加。这表明三元Env(NYP)-CD4-CCR5(Δ18)复合物在亚阈值温度下积累,并且与截短的共受体的低亲和力相互作用足以触发Env(NYP)的gp41构象变化,但不能触发野生型Env的gp41构象变化。我们还证明,在存在对应于CCR5 Nt的合成硫酸化肽的情况下,CCR5(Δ18)支持野生型Env介导的融合和感染的能力可以部分恢复。在亚阈值温度下用硫酸化肽对表达野生型Env和CCR5(Δ18)的细胞进行预孵育显著提高了融合效率。
我们提出,在结合CCR5的Nt区域后,野生型Env获得了有效结合CCR5细胞外环的能力——这一事件触发gp41重折叠和膜融合。Env(NYP)中的适应性突变使其即使在没有硫酸化肽的情况下与严重受损的共受体弱相互作用时,也能更容易地释放对gp41的控制。